<p><b>(A)</b> NIH3T3 cells were serum-starved for 24 h (a) and then stimulated with 10% serum (b) or 100 ng/mL FGF4 (f). In other conditions, cells were pretreated with 20 μM U0126 (c, e, g) or vehicle DMSO (d, h) for 30 min before stimulation with 10% serum (c, d) or FGF4 (g, h). Cells were fixed, processed for double immunofluorescence with antibodies against total ERK1/2 and activated di-phosphorylated YT-ERK1/2, and then imaged by confocal microscopy. A maximum-intensity projection of a 5-μm thick z-stack (step size: 0.3 μm) for each overlapping image is shown. <b>(B)</b> NIH-3T3 cells were transiently transfected with increasing amounts of eGFP-rERK2 plasmid as indicated on the top left of each image, serum-starved for 24 h, fixed, and...
<p>(A,B) AD293 cells overexpress EGFRvIII, EGFRwt or both receptor variants. Cells were cultured in ...
<p>(A) Time-course of EGF stimulation on FAK gene transcription activation in B16F1 cells. The B16F1...
<p>(<b>A</b>) AKR-2B and NIH 3T3 fibroblast were treated with TGF-β (2 ng/ml) for times ranging from...
<p><b>(A)</b> eGFP-transfected NIH-3T3 cells were fixed. Individual living cells were imaged as desc...
<p><b>A</b>) The graph show the growth curves of mock- and ERβ-transfected REN cell treated for 24 a...
<p>A. CHO cells stably expressing αPIX<sup>WT</sup> or CAT (control) were transfected with EGFR expr...
<p>A) Representative fields of fibroblast treated for 24 hr with 10% serum. In this example, cells h...
<p>(<b>A</b>) Co-immunoprecipitation of DOK2, EGFR, and RASA1. HEK293 cells were co-transfected with...
<p><b>(A)</b> Immunoblot of phospho-ERK 1/2 and total-ERK 1/2 in VC or iAβ transduced HEK293 cells f...
<p>(A) Transient phosphorylation of MEK and ERK and induction of αSMA expression by TGF-β1 stimulati...
<p>A. Stable αPIX<sup>WT</sup> and control (CAT) CHO cell lines were transiently transfected with EG...
<p>LP07 cells were transiently transfected with wild type ERK2-V5 (wt), using Lipofectamine 2000 rea...
<p>A) Cells transfected with ERK1-GFP in control conditions and after treatment with 80 ng/ml of FGF...
<p><b>A</b>) Immunocytochemistry analysis of RKIP in glioma cell lines cells with both nuclear and c...
<p>(A) NIH 3T3 fibroblasts were triply transfected with CIBN-CaaX, CRY2PHR-mCherry-Raf1, and ERK2-GF...
<p>(A,B) AD293 cells overexpress EGFRvIII, EGFRwt or both receptor variants. Cells were cultured in ...
<p>(A) Time-course of EGF stimulation on FAK gene transcription activation in B16F1 cells. The B16F1...
<p>(<b>A</b>) AKR-2B and NIH 3T3 fibroblast were treated with TGF-β (2 ng/ml) for times ranging from...
<p><b>(A)</b> eGFP-transfected NIH-3T3 cells were fixed. Individual living cells were imaged as desc...
<p><b>A</b>) The graph show the growth curves of mock- and ERβ-transfected REN cell treated for 24 a...
<p>A. CHO cells stably expressing αPIX<sup>WT</sup> or CAT (control) were transfected with EGFR expr...
<p>A) Representative fields of fibroblast treated for 24 hr with 10% serum. In this example, cells h...
<p>(<b>A</b>) Co-immunoprecipitation of DOK2, EGFR, and RASA1. HEK293 cells were co-transfected with...
<p><b>(A)</b> Immunoblot of phospho-ERK 1/2 and total-ERK 1/2 in VC or iAβ transduced HEK293 cells f...
<p>(A) Transient phosphorylation of MEK and ERK and induction of αSMA expression by TGF-β1 stimulati...
<p>A. Stable αPIX<sup>WT</sup> and control (CAT) CHO cell lines were transiently transfected with EG...
<p>LP07 cells were transiently transfected with wild type ERK2-V5 (wt), using Lipofectamine 2000 rea...
<p>A) Cells transfected with ERK1-GFP in control conditions and after treatment with 80 ng/ml of FGF...
<p><b>A</b>) Immunocytochemistry analysis of RKIP in glioma cell lines cells with both nuclear and c...
<p>(A) NIH 3T3 fibroblasts were triply transfected with CIBN-CaaX, CRY2PHR-mCherry-Raf1, and ERK2-GF...
<p>(A,B) AD293 cells overexpress EGFRvIII, EGFRwt or both receptor variants. Cells were cultured in ...
<p>(A) Time-course of EGF stimulation on FAK gene transcription activation in B16F1 cells. The B16F1...
<p>(<b>A</b>) AKR-2B and NIH 3T3 fibroblast were treated with TGF-β (2 ng/ml) for times ranging from...